{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:30:57Z","timestamp":1794335457100,"version":"4.9.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"Supplement_C","license":[{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Late gadolinium enhancement (LGE) is the most relevant tool of cardiac magnetic resonance for tissue characterization, and it plays a pivotal role for diagnostic and prognostic assessment of cardiomyopathies. The pattern of presentation of LGE allows differential diagnosis between ischaemic and non-ischaemic heart disease with high diagnostic accuracy, and among different cardiomyopathies, specific presentation of LGE may help to make a diagnosis. Late gadolinium enhancement may be caused by conditions that significantly increase the interstitial space or, less frequently, that slow down Gd exit, like myocardial fibrosis. In chronic myocardial infarction, hypertrophic cardiomyopathies (HCM), dilated cardiomyopathy, Fabry disease, and other conditions, LGE is a marker of myocardial fibrosis, but also in patients with acute myocarditis where LGE may be also explained by the increase of interstitial space caused by interstitial oedema or by tissue infiltration of inflammatory cells. In cardiac amyloidosis, LGE represents myocardial fibrosis but the interstitial overload of amyloid proteins should also be considered as a potential cause of LGE. The identification of the pattern of presentation of LGE is also very important. In the ischaemic pattern, LGE always involves the subendocardial layer with more or less transmural extent, it is confluent, and every single scar should be located in the territory of one coronary artery. In the non-ischaemic pattern, LGE does not fulfil the previous criteria, being midwall, subepicardial, or mixed, not necessarily confluent or confined to a territory of one coronary artery. For cardiomyopathies, the exact pattern of non-ischaemic LGE is important. Quantitative analysis of LGE is required in some specific conditions as in HCM. Magnetic resonance imaging with LGE technique should be performed in every patient with suspect of cardiomyopathy. The lack of standardization of pulse sequence and mostly of quantification methods is the main limitation of LGE technique.<\/jats:p>","DOI":"10.1093\/eurheartjsupp\/suad015","type":"journal-article","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T01:22:53Z","timestamp":1675473773000},"page":"C130-C136","source":"Crossref","is-referenced-by-count":99,"title":["Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies"],"prefix":"10.1093","volume":"25","author":[{"given":"Giovanni Donato","family":"Aquaro","sequence":"first","affiliation":[{"name":"Academic Radiology, University of Pisa , Via Savi 10, 56126 Pisa , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"De Gori","sequence":"additional","affiliation":[{"name":"Academic Radiology, University of Pisa , Via Savi 10, 56126 Pisa , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Faggioni","sequence":"additional","affiliation":[{"name":"Academic Radiology, University of Pisa , Via Savi 10, 56126 Pisa , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Parisella","sequence":"additional","affiliation":[{"name":"Academic Radiology, University of Pisa , Via Savi 10, 56126 Pisa , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania","family":"Cioni","sequence":"additional","affiliation":[{"name":"Academic Radiology, University of Pisa , Via Savi 10, 56126 Pisa , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Lencioni","sequence":"additional","affiliation":[{"name":"Academic Radiology, University of Pisa , Via Savi 10, 56126 Pisa , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Neri","sequence":"additional","affiliation":[{"name":"Academic Radiology, University of Pisa , Via Savi 10, 56126 Pisa , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"key":"2023042617350067500_suad015-B1","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jacc.2017.08.044","article-title":"Cardiac MR with late gadolinium enhancement in acute myocarditis with preserved systolic function: ITAMY study","volume":"70","author":"Aquaro","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2023042617350067500_suad015-B2","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/CIRCULATIONAHA.105.606509","article-title":"Presentation, patterns of myocardial damage, and clinical course of viral myocarditis","volume":"114","author":"Mahrholdt","year":"2006","journal-title":"Circulation"},{"key":"2023042617350067500_suad015-B3","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2022.01.036","article-title":"Critical comparison of documents from scientific societies on cardiac amyloidosis: JACC state-of-the-art review","volume":"79","author":"Rapezzi","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2023042617350067500_suad015-B4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/jmri.23605","article-title":"Cardiac imaging techniques for physicians: late enhancement","volume":"36","author":"Kellman","year":"2012","journal-title":"J Magn Reson Imaging"},{"key":"2023042617350067500_suad015-B5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1081\/JCMR-120022267","article-title":"How we perform delayed enhancement imaging","volume":"5","author":"Kim","year":"2003","journal-title":"J Cardiovasc Magn Reson"},{"key":"2023042617350067500_suad015-B6","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.acra.2007.06.017","article-title":"Phase-sensitive inversion recovery single-shot balanced steady-state free precession for detection of myocardial infarction during a single breathhold","volume":"14","author":"Huber","year":"2007","journal-title":"Acad Radiol"},{"key":"2023042617350067500_suad015-B7","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/europace\/euu310","article-title":"3D delayed-enhanced magnetic resonance sequences improve conducting channel delineation prior to ventricular tachycardia ablation","volume":"17","author":"Andreu","year":"2015","journal-title":"Europace"},{"key":"2023042617350067500_suad015-B8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1148\/radiol.11102216","article-title":"Acute, subacute, and chronic myocardial infarction: quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging","volume":"259","author":"Goetti","year":"2011","journal-title":"Radiology"},{"key":"2023042617350067500_suad015-B9","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/jmri.21897","article-title":"Left ventricular infarct size, peri-infarct zone, and papillary scar measurements: a comparison of high-resolution 3D and conventional 2D late gadolinium enhancement cardiac MR","volume":"30","author":"Peters","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"2023042617350067500_suad015-B10","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1148\/radiol.2303021411","article-title":"Myocardial viability: breath-hold 3D MR imaging of delayed hyperenhancement with variable sampling in time","volume":"230","author":"Foo","year":"2004","journal-title":"Radiology"},{"key":"2023042617350067500_suad015-B11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jcmg.2010.11.015","article-title":"Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance","volume":"4","author":"Flett","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023042617350067500_suad015-B12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1532-429X-12-21","article-title":"Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy","volume":"12","author":"Aquaro","year":"2010","journal-title":"J Cardiovasc Magn Reson"},{"key":"2023042617350067500_suad015-B13","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.010489","article-title":"Late gadolinium enhancement-dispersion mapping: a new magnetic resonance imaging technique to assess prognosis in patients with hypertrophic cardiomyopathy and low-intermediate 5-year risk of sudden death","volume":"13","author":"Aquaro","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023042617350067500_suad015-B14","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"2023042617350067500_suad015-B15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"2023042617350067500_suad015-B16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jacc.2018.05.060","article-title":"Late gadolinium enhancement in patients with hypertrophic cardiomyopathy and preserved systolic function","volume":"72","author":"Mentias","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023042617350067500_suad015-B17","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.amjcard.2019.07.023","article-title":"Prognostic role of late gadolinium enhancement in patients with hypertrophic cardiomyopathy and low-to-intermediate sudden cardiac death risk score","volume":"124","author":"Todiere","year":"2019","journal-title":"Am J Cardiol"},{"key":"2023042617350067500_suad015-B18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ejhf.1461","article-title":"Heart failure in cardiomyopathies: a position paper from the heart failure association of the European society of cardiology","volume":"21","author":"Seferovi\u0107","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2023042617350067500_suad015-B19","first-page":"e533","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: A report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"2023042617350067500_suad015-B20","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3390\/diagnostics12112652","article-title":"Cardiac magnetic resonance in fabry disease: morphological, functional, and tissue features","volume":"12","author":"Aquaro","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2023042617350067500_suad015-B21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","article-title":"Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment","volume":"119","author":"Weidmann","year":"2009","journal-title":"Circulation"},{"key":"2023042617350067500_suad015-B22","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.amjcard.2005.11.087","article-title":"Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in fabry\u2019s cardiomyopathy","volume":"97","author":"Beer","year":"2006","journal-title":"Am J Cardiol"},{"key":"2023042617350067500_suad015-B23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jjcc.2019.09.002","article-title":"Clinical findings of gadolinium-enhanced cardiac magnetic resonance in fabry patients","volume":"75","author":"Nojiri","year":"2020","journal-title":"J Cardiol"},{"key":"2023042617350067500_suad015-B24","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N Engl J Med"},{"key":"2023042617350067500_suad015-B25","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jcmg.2018.03.006","article-title":"The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: A review and meta-analysis","volume":"11","author":"Becker","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023042617350067500_suad015-B26","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.jcmg.2018.07.015","article-title":"Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement","volume":"12","author":"Halliday","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023042617350067500_suad015-B27","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.jacc.2020.04.023","article-title":"Prognostic value of magnetic resonance phenotype in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"75","author":"Aquaro","year":"2020","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/25\/Supplement_C\/C130\/50100074\/suad015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/25\/Supplement_C\/C130\/50100074\/suad015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T13:36:06Z","timestamp":1682516166000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/25\/Supplement_C\/C130\/7143251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":27,"journal-issue":{"issue":"Supplement_C","published-online":{"date-parts":[[2023,4,26]]},"published-print":{"date-parts":[[2023,4,26]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartjsupp\/suad015","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5,1]]},"published":{"date-parts":[[2023,4,26]]}}}